RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yasmine Kanaan to Female

This is a "connection" page, showing publications Yasmine Kanaan has written about Female.
Connection Strength

0.410
  1. Qasim M, Ricks-Santi LJ, Naab TJ, Rajack F, Beyene D, Abbas M, Kassim OO, Copeland RL, Kanaan Y. Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women. Cancer Genomics Proteomics. 2022 Nov-Dec; 19(6):673-682.
    View in: PubMed
    Score: 0.055
  2. Copeland RL, Kanaan Y. New targets in triple-negative breast cancer. Nat Rev Cancer. 2021 12; 21(12):744.
    View in: PubMed
    Score: 0.052
  3. Turkistani S, Sugita BM, Fadda P, Marchi R, Afsari A, Naab T, Apprey V, Copeland RL, Campbell MC, Cavalli LR, Kanaan Y. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer. BMC Cancer. 2021 Jul 27; 21(1):861.
    View in: PubMed
    Score: 0.051
  4. Owrang M, Copeland RL, Ricks-Santi LJ, Gaskins M, Beyene D, Dewitty RL, Kanaan YM. Breast Cancer Prognosis for Young Patients. In Vivo. 2017 Jul-Aug; 31(4):661-668.
    View in: PubMed
    Score: 0.038
  5. Kanaan YM, Sampey BP, Beyene D, Esnakula AK, Naab TJ, Ricks-Santi LJ, Dasi S, Day A, Blackman KW, Frederick W, Copeland RL, Gabrielson E, Dewitty RL. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease. Cancer Genomics Proteomics. 2014 Nov-Dec; 11(6):279-94.
    View in: PubMed
    Score: 0.032
  6. Aloufi A, Aubee J, Vargas KM, Apprey V, Thompson K, Copeland R, Kanaan Y, Ricks-Santi L, Brim H, Abbas M. Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women. Gene. 2024 Nov 15; 927:148695.
    View in: PubMed
    Score: 0.015
  7. Kanaan Y, Kpenu E, Utley K, Adams-Campbell L, Dunston GM, Brody LC, Broome C. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet. 2003 Oct; 113(5):452-60.
    View in: PubMed
    Score: 0.015
  8. Almohaywi M, Sugita BM, Centa A, Fonseca AS, Antunes VC, Fadda P, Mannion CM, Abijo T, Goldberg SL, Campbell MC, Copeland RL, Kanaan Y, Cavalli LR. Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients. Int J Mol Sci. 2023 Aug 22; 24(17).
    View in: PubMed
    Score: 0.015
  9. Cheng X, Murthy SRK, Zhuang T, Ly L, Jones O, Basadonna G, Keidar M, Kanaan Y, Canady J. Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA. Int J Mol Sci. 2021 Sep 03; 22(17).
    View in: PubMed
    Score: 0.013
  10. Yan Y, Narayan A, Cho S, Cheng Z, Liu JO, Zhu H, Wang G, Wharram B, Lisok A, Brummet M, Saeki H, Huang T, Gabrielson K, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Yfantis HG, Ambs S, Pomper MG, Sukumar S, Merino VF. CRY?B2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Oncogene. 2021 09; 40(38):5752-5763.
    View in: PubMed
    Score: 0.013
  11. Robinson AGJ, Kanaan YM, Copeland RL. Combinatorial Cytotoxic Effects of 2,3-Dichloro-5,8-dimethoxy-1,4-naphthoquinone and 4-hydroxytamoxifen in Triple-negative Breast Cancer Cell Lines. Anticancer Res. 2020 Dec; 40(12):6623-6635.
    View in: PubMed
    Score: 0.012
  12. Ren X, Ghassemi P, Kanaan YM, Naab T, Copeland RL, Dewitty RL, Kim I, Strobl JS, Agah M. Kernel-Based Microfluidic Constriction Assay for Tumor Sample Identification. ACS Sens. 2018 08 24; 3(8):1510-1521.
    View in: PubMed
    Score: 0.010
  13. Khan F, Ricks-Santi LJ, Zafar R, Kanaan Y, Naab T. Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women. Ann Diagn Pathol. 2018 Jun; 34:170-174.
    View in: PubMed
    Score: 0.010
  14. Khan F, Esnakula A, Ricks-Santi LJ, Zafar R, Kanaan Y, Naab T. Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women. Pathol Res Pract. 2018 May; 214(5):673-678.
    View in: PubMed
    Score: 0.010
  15. Naab TJ, Gautam A, Ricks-Santi L, Esnakula AK, Kanaan YM, DeWitty RL, Asgedom G, Makambi KH, Abawi M, Blancato JK. MYC amplification in subtypes of breast cancers in African American women. BMC Cancer. 2018 03 09; 18(1):274.
    View in: PubMed
    Score: 0.010
  16. Ricks-Santi LJ, Barley B, Winchester D, Sultan D, McDonald J, Kanaan Y, Pearson-Fields A, Sutton AL, Sheppard V, Williams C. Affluence Does Not Influence Breast Cancer Outcomes in African American Women. J Health Care Poor Underserved. 2018; 29(1):509-529.
    View in: PubMed
    Score: 0.010
  17. Ricks-Santi L, McDonald JT, Gold B, Dean M, Thompson N, Abbas M, Wilson B, Kanaan Y, Naab TJ, Dunston G. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. Ethn Dis. 2017; 27(2):169-178.
    View in: PubMed
    Score: 0.009
  18. Sheppard VB, Cavalli LR, Dash C, Kanaan YM, Dilawari AA, Horton S, Makambi KH. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer. Clin Breast Cancer. 2017 06; 17(3):232-238.
    View in: PubMed
    Score: 0.009
  19. Barfield WL, Uaesoontrachoon K, Wu CS, Lin S, Chen Y, Wang PC, Kanaan Y, Bond V, Hoffman EP. Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage. Hum Mol Genet. 2014 Aug 01; 23(15):4043-50.
    View in: PubMed
    Score: 0.008
  20. Esnakula AK, Ricks-Santi L, Kwagyan J, Kanaan YM, DeWitty RL, Wilson LL, Gold B, Frederick WA, Naab TJ. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women. J Clin Pathol. 2014 Feb; 67(2):153-60.
    View in: PubMed
    Score: 0.007
  21. Ricks-Santi LJ, Nie J, Marian C, Ochs-Balcom HM, Trevisan M, Edge SB, Kanaan Y, Freudenheim JL, Shields PG. BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study. Genet Epidemiol. 2013 Jul; 37(5):504-11.
    View in: PubMed
    Score: 0.007
  22. Yu W, Kanaan Y, Bae YK, Baed YK, Gabrielson E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet Cytogenet. 2009 Aug; 193(1):29-37.
    View in: PubMed
    Score: 0.006
  23. Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res. 2004 Mar 15; 10(6):2052-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support